Not Yet RecruitingNot Applicable

Comprehensive Geriatric Assessment in Adults Aged 40 Years and Older Living With HIV

80 participantsStarted 2026-03-02

Plain-language summary

People living with HIV are experiencing longer life expectancy due to effective antiretroviral therapy; however, they may develop age-related conditions earlier than the general population. This prospective observational study aims to evaluate frailty, sarcopenia, nutritional status, cognitive function, and functional performance in adults aged 40 years and older living with HIV and to compare them with age- and sex-matched healthy controls.

Who can participate

Age range40 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Age ≥ 40 years Confirmed diagnosis of HIV infection (for HIV group) On stable antiretroviral therapy for at least 6 months (for HIV group) HIV-negative status confirmed by medical history or testing (for control group) Ability to provide informed consent Exclusion Criteria: Acute infection or hospitalization within the last 4 weeks Known active malignancy under treatment Severe psychiatric disorder interfering with assessment Severe cognitive impairment preventing participation

What they're measuring

Prevalence of Frailty

Timeframe: Baseline

Trial details

NCT IDNCT07453303

SponsorSehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-04-20

View on ClinicalTrials.gov More Frailty trials